MICHELLE MEYERS: Open Payments
NPI 1205244860 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 22 payments from 14 companies in 2025. Trend: 2023 $191 · 2024 $204 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $162 |
| Viatris Specialty LLC | 5 | $114 |
| Grifols USA, LLC | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
Products named: TEZSPIRE, YUPELRI, Prolastin-C Liquid, DUPIXENT, BREZTRI, OFEV, INSPIRE, Sunosi.
Industry payments across SD — which companies pay providers there.
